Shrikant Nema

Dr. Shrikant Nema

International Centre for Genetic Engineering and Biotechnology, New Delhi, Delhi, International
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PBPraveen Kumar Bharti
Praveen Kumar Bharti
HCHimanshu Singh Chandel
Himanshu Singh Chandel
SKSri Krishna
Sri Krishna
Shrikant NemaShrikant Nema
Shrikant Nema
AAAmreen Ahmad
Amreen Ahmad
NSNeeru Singh
Neeru Singh
Commercial malaria rapid diagnostic tests (RDTs) detectP. falciparumhistidine rich protein 2 (PfHRP2) and cross react withPfHRP3, a structural homologue. Here, we analysed natural variations inPfHRP2 andPfHRP3 sequences from Indian isolates and correlated these variations with RDT reactivity. A total 1392 P. falciparumpositive samples collected from eight endemic states were PCR amplified forPfhrp2andPfhrp3genes and were sequenced. The deduced protein sequences were analysed for repeat variations and correlated with RDT reactivity. Out of 1392 PCR amplified samples, a single sample wasPfhrp2negative and two samples werePfhrp3negative. CompletePfhrp2 andPfhrp3 sequences were obtained for 769 samples and 750 samples, respectively. A total of 16 distinct repeat motifs were observed forPfhrp2and 11 forPfhrp3, including some new repeat types. No correlation was found between variations in the size ofPfhrp2repeat types 2 and 7, nor between any combinations of repeat motifs, and performance of a commercial RDT at low parasite densities. The findings suggest that sequence diversity inPfhrp2andPfhrp3genes in Indian isolates is not likely to negatively influence performance of currently usedPfHRP2 RDTs.

29 July 2020 in Indian Pediatrics
Verified
Journal Article
Closed access
PDF file
Shrikant NemaShrikant Nema
Shrikant Nema
PGPawan Ghanghoria
Pawan Ghanghoria
PBPraveen kumar Bharti
Praveen kumar Bharti

3 August 2022 in The Lancet Regional Health - Southeast Asia
Verified
Journal Article
Open access
Shrikant NemaShrikant Nema
Shrikant Nema
Manju RahiManju Rahi
Manju Rahi
ASAmit Sharma
Amit Sharma
PBPraveen kumar Bharti
Praveen kumar Bharti

1 December 2019 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
Shrikant NemaShrikant Nema
Shrikant Nema
AVAnil Kumar Verma
Anil Kumar Verma
PBPraveen kumar Bharti
Praveen kumar Bharti

1 February 2021 in Trends in Parasitology
Verified
Journal Article
Closed access
Shrikant NemaShrikant Nema
Shrikant Nema
AVAnil Kumar Verma
Anil Kumar Verma
ATArchana Tiwari
Archana Tiwari
PBPraveen kumar Bharti
Praveen kumar Bharti

28 January 2022 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
Shrikant NemaShrikant Nema
Shrikant Nema
ASAkansha Singh
Akansha Singh
SKSri Krishna
Sri Krishna
RPRajan Poriya
Rajan Poriya
SDShivangi Dubey
Shivangi Dubey
PBPraveen kumar Bharti
Praveen kumar Bharti
Background: In India, there are several malaria-endemic regions where non-falciparum species coexist with Plasmodium falciparum. Traditionally, microscopy and rapid diagnostic tests are used for the diagnosis of malaria. Nevertheless, microscopy often misses the secondary malaria parasite in mixed-infection cases due to various constraints. Misdiagnosis/misinterpretation of Plasmodium species leads to improper treatment, as the treatment for P. falciparum and Plasmodium vivax species is different, as per the national vector-borne disease control program in India. Methods: Blood samples were collected from malaria-endemic regions (Jharkhand, Madhya Pradesh, Chhattisgarh, Maharashtra, Odisha, Assam, Meghalaya, Mizoram and Telangana) of India covering almost the entire country. Molecular diagnosis of Plasmodium species was carried out among microscopically confirmed P. falciparum samples collected during a therapeutic efficacy study in different years. Results: The polymerase chain reaction analysis revealed a high prevalence (18%) of mixed malaria parasite infections among microscopically confirmed P. falciparum samples from malaria patients that are either missed or left out by microscopy. Conclusions: Deployment of molecular tools in areas of mixed species infection may prove vital for accurate diagnosis and treatment of malaria. Further, it will help in achieving the goal of malaria elimination in India.